cannabis news Archives - Digipath Inc. - When Science Matters

GroSciences moves forward with TERP+ Broadspectum, a cannabis based all-natural pesticide.

Digipath’s GroSciences Moving Forward with Further Testing for its Patent Pending All-Natural, Plant-Derived Pesticide

BOULDER, CO, August 14, 2019 – Digipath, Inc. (OTCQB: DIGP), a service-oriented independent testing laboratory, data analytics and formulation firm focused on the developing cannabis and hemp markets, is pleased to announce that its GroSciences division has successfully completed preliminary validation testing on its patent pending all-natural, plant-derived pesticide, TERPO+ Broadspectrum. The product could potentially

Continue Reading
Digipath Inc. CEO Todd Denkin was recently interviewed on Stock Day by Everett Jolly.

Digipath Inc. CEO Todd Denkin Stock Day Podcast Interview

Digipath Inc. CEO Todd Denkin was recently interviewed by Everett Jolly on the Stock Day Podcast to discuss what has been happening with Digipath Inc. and it’s subsidiaries. He discusses the move to Colombia and its potential for Digipath Labs and GroSciences. Colombia is expected to control a great deal of the global cannabis export

Continue Reading

Letter to Shareholders

From the Office of the CEO April 13, 2015 Fellow DigiPath Shareholders: We expect to open our first cannabis analytical testing laboratory in just a few short weeks, and it looks like we’ll be one of the first labs to open in Nevada. As we help usher medicinal marijuana into the Silver State, I wanted

Continue Reading

Letter to Shareholders

From the Office of the CEO Fellow DigiPath Shareholders: This is a very exciting time to be involved in the digital pathology and cannabis industries, and as investors in DigiPath, Inc., you and I are stakeholders in both. As co-founder, and now CEO, of DigiPath, Inc., I am always looking to improve things—including how we

Continue Reading